Chairman of the Executive Committee, CEO, Executive Director
Dr. Roch Doliveux has served as Executive Director of UCB S.A. since January 1 2015. He was Chief Executive Office and Chairman of the Executive Committee of the Company until January 1 2015. He is Doctor in Veterinarian Medicine from MaisonsAlfort Mr. Doliveux is also Laureate of the Faculty of Medicine Creteil and holds a Masters of Business Administration from INSEAD with distinction. He joined the pharmaceutical industry early first at CibaGeigy in Switzerland in Peru and in France and then at ScheringPlough Corporationrationration in various positions including President of ScheringPlough International. Then Roch Doliveux joined the Pierre Fabre group a Chief Executive Officer of Pierre Fabre Pharmaceuticals
Age: 58 Chairman Since 2015 Ph.DDoliveux joined UCB in October 2003 as Director General of the Pharma Sector and Deputy Chairman of the Executive Committee. He became CEO and Chairman of the Executive Committee of UCB on January 1, 2005. He is a member of the Board of Directors of UCB, Member of the Board of Stryker Corporationrationrationration in the United States, as well as a member of the Board of the European Federation of Pharmaceutical Association, the Innovative Medicines Initiative which is a publicprivate partnership between the European Union and EFPIA, WELBIO, the INSEAD International Council and Chairman of the Caring Entrepreneurship Fund . He was awarded the Doctor Honoris Causa degree of the University of Liege in October 2011.